MedTrace Logo

Effects of Atazanavir Treatment on Type 2 Diabetes Mellitus Related Endothelial Dysfunction

NCT00696722 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2010-01-26

No results posted yet for this study

Summary

The purpose of this study is to determine whether atazanavir use is of influence on the endothelial dysfunction associated with type 2 diabetes mellitus.

Conditions

  • Type 2 Diabetes Mellitus Related Endothelial Dysfunction

Interventions

DRUG

placebo + atazanavir

Placebo treatment first, atazanavir treatment second 4 day treatment

DRUG

atazanavir + placebo

Atazanavir treatment first, placebo treatment second 4 day treatment

Sponsors & Collaborators

  • Dutch Diabetes Research Foundation

    collaborator OTHER

  • Radboud University Medical Center

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2009-03-31
Completion
2009-03-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00696722 on ClinicalTrials.gov